AEROVATE THERAPEUTICS INC (AVTE) Stock Price & Overview
NASDAQ:AVTE • US0080641071
Current stock price
The current stock price of AVTE is 2.68 USD. Today AVTE is down by 0%. In the past month the price increased by 5.93%. In the past year, price decreased by -86.79%.
AVTE Key Statistics
- Market Cap
- 77.693M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.44
- Dividend Yield
- N/A
AVTE Stock Performance
AVTE Stock Chart
AVTE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to AVTE. When comparing the yearly performance of all stocks, AVTE is a bad performer in the overall market: 91.08% of all stocks are doing better.
AVTE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AVTE. No worries on liquidiy or solvency for AVTE as it has an excellent financial health rating, but there are worries on the profitability.
AVTE Earnings
AVTE Forecast & Estimates
AVTE Groups
Sector & Classification
AVTE Financial Highlights
Over the last trailing twelve months AVTE reported a non-GAAP Earnings per Share(EPS) of -2.44. The EPS increased by 15.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.68% | ||
| ROE | -91.1% | ||
| Debt/Equity | 0 |
AVTE Ownership
AVTE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.04 | 388.573B | ||
| AMGN | AMGEN INC | 15.4 | 194.674B | ||
| GILD | GILEAD SCIENCES INC | 15.98 | 179.261B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.29 | 117.486B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.92 | 80.247B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.19 | 42.494B | ||
| INSM | INSMED INC | N/A | 31.024B | ||
| NTRA | NATERA INC | N/A | 28.116B | ||
| BIIB | BIOGEN INC | 11.34 | 27.193B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.76 | 23.669B | ||
| MRNA | MODERNA INC | N/A | 21.299B | ||
| EXAS | EXACT SCIENCES CORP | 341.33 | 19.841B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.645B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVTE
Company Profile
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2021-06-30. The firm is in the process of exploring strategic alternatives, which may include, but are not limited to, an acquisition, merger, reverse merger, business combination, liquidation or other transaction.
Company Info
IPO: 2021-06-30
AEROVATE THERAPEUTICS INC
930 Winter Street, Suite M-500
Waltham MASSACHUSETTS US
CEO: Timothy P. Noyes
Employees: 51
Phone: 16174432400
AEROVATE THERAPEUTICS INC / AVTE FAQ
Can you describe the business of AEROVATE THERAPEUTICS INC?
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2021-06-30. The firm is in the process of exploring strategic alternatives, which may include, but are not limited to, an acquisition, merger, reverse merger, business combination, liquidation or other transaction.
What is the current price of AVTE stock?
The current stock price of AVTE is 2.68 USD.
Does AEROVATE THERAPEUTICS INC pay dividends?
AVTE does not pay a dividend.
What is the ChartMill rating of AEROVATE THERAPEUTICS INC stock?
AVTE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of AVTE stock?
AEROVATE THERAPEUTICS INC (AVTE) operates in the Health Care sector and the Biotechnology industry.
Should I buy AVTE stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVTE.